India, June 11 -- Zydus has received the Establishment Inspection Report (EIR) from the USFDA for its API manufacturing facility in Ankleshwar. The facility was inspected between March 10 and 14, 2025, and the inspection has been classified as "No Action Indicated" (NAI). The USFDA has officially closed the inspection.
This disclosure is being made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....